US Eye
PrivateLast Round
Growth Equity
Jul 16, 2019
Company Overview
US Eye operates in Healthcare & Life Sciences and is based in Sarasota, Florida. Its latest recorded funding round was a Growth Equity round in July 2019.
US Eye is a healthcare services company that operates a physician-led, vertically integrated network of ophthalmology, optometry, and multi-specialty eye care practices and surgery centers.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, EHR & EMR, Medical Devices, Revenue Cycle
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
US Eye Comparables
Compare US Eye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| American Vision Partners | 93% | |
| EyeCare Partners | 90% | |
| ReFocus Eye Health | 89% |
For institutional investors. Book with your work email.
US Eye Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
US Eye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pamlico Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 264% MoM, reaching 15.9K.
- Jul 16, 2025
Grew 537% QoQ, from 138 to 879 employees.
For institutional investors. Book with your work email.
US Eye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about US Eye's valuation, stock price, and market status.
Is US Eye a public or private company?
US Eye is a private company.
What is the current stock price of US Eye?
US Eye is a private company, so its shares have no public market price. Caplight tracks US Eye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is US Eye worth (valuation)?
Valuation information for US Eye is not publicly available.
Can I buy US Eye stock?
US Eye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was US Eye's last funding round?
US Eye's most recent funding round was Growth Equity on July 16, 2019.
Who are the main investors in US Eye?
Key investors in US Eye include Pamlico Capital.
Will US Eye IPO soon?
No public IPO plans have been announced for US Eye.
How can I track US Eye secondary market activity?
Caplight tracks bids, offers, and trades in US Eye's shares on secondary markets.